ESR2 and breast carcinoma: The overexpression of ERβ has also been linked in breast cancer cells to a reduction in Akt signalling and thus a reduction in pro-tumorigenic processes35; however, in the present study T47D cells consistently presented higher AKT expression that was enhanced by whole blood exposure.